![Shirish Hirani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shirish Hirani
Geen lopende functies
Profiel
Shirish Hirani worked as Vice President of Drug Development at ARIAD Pharmaceuticals, Inc. from 2005 to 2017.
Prior to that, he held the same position at Transkaryotic Therapies, Inc. from 2002 to 2005 and was Senior Vice President of Product Development at Dyax Corp.
from 1997 to 2002.
He also served as SVP of Program Management & Product Planning at ArQule, Inc. Dr. Hirani received his undergraduate and doctorate degrees from Queen Elizabeth College.
Eerdere bekende functies van Shirish Hirani
| Bedrijven | Functie | Einde |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2017 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Corporate Officer/Principal | 01-01-2005 |
| DYAX CORP. | Corporate Officer/Principal | 01-01-2002 |
| ARQULE, INC. | Corporate Officer/Principal | - |
Opleiding van Shirish Hirani
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Queen Elizabeth College
 Queen Elizabeth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
